Fina Biotech - Product Pipeline Analysis, 2014 Update

Date: June 6, 2014
Pages: 19
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: FE3C4B47592EN
Leaflet:

Download PDF Leaflet

Fina Biotech - Product Pipeline Analysis, 2014 Update
Fina Biotech (Fina) is a biotechnology company. The company selects, finances, conducts, develops and sells biotechnology projects. It offers in vitro diagnostic product Halosperm, which is a kit to determine the degree of DNA fragmentation in human sperm, using sperm chromatin dispersion (SCD) technique. It produces new tools for monitoring, diagnosis, prognosis and treatment of significant diseases. Fina investments in the areas of oncology, cardiology and stem cell therapy. The company’s diagnostics areas include bladder cancer, restenosis, bio energetic signature, prostate cancer, colon cancer, deep vein thromobos, myocardial infarction, and brain stroke. It partners with halotech, SF biotech, abg patentes, HERRERO & ASOCIADOS, and others. Fina is headquartered in Madrid, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Fina Biotech
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Fina Biotech Company Snapshot
Fina Biotech Company Overview
Key Information
Fina Biotech Pipeline Products and Clinical Trials Overview
Fina Biotech – Pipeline Analysis Overview
Key Facts
Fina Biotech - Major Products and Services
Fina Biotech Pipeline Products by Development Stage
Fina Biotech Pipeline Products Overview
Bioenergetic Signature Of Cancer
Bioenergetic Signature Of Cancer Product Overview
Dx Bioenergetic Signature - Breast Cancer
Dx Bioenergetic Signature - Breast Cancer Product Overview
Dx Colon Cancer
Dx Colon Cancer Product Overview
Dx Prostate Cancer
Dx Prostate Cancer Product Overview
RES - Chip Lung Cancer Assay
RES - Chip Lung Cancer Assay Product Overview
Fina Biotech - Key Competitors
Fina Biotech - Key Employees
Fina Biotech - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Fina Biotech, Key Facts
Fina Biotech Pipeline Products and Clinical Trials Overview
Fina Biotech Pipeline Products by Equipment Type
Fina Biotech Pipeline Products by Indication
Fina Biotech, Key Facts
Fina Biotech, Major Products and Services
Fina Biotech Number of Pipeline Products by Development Stage
Fina Biotech Pipeline Products Summary by Development Stage
Bioenergetic Signature Of Cancer - Product Status
Bioenergetic Signature Of Cancer - Product Description
Dx Bioenergetic Signature - Breast Cancer - Product Status
Dx Bioenergetic Signature - Breast Cancer - Product Description
Dx Colon Cancer - Product Status
Dx Colon Cancer - Product Description
Dx Prostate Cancer - Product Status
Dx Prostate Cancer - Product Description
RES - Chip Lung Cancer Assay - Product Status
RES - Chip Lung Cancer Assay - Product Description
Fina Biotech, Key Employees

LIST OF FIGURES

Fina Biotech Pipeline Products by Equipment Type
Fina Biotech Pipeline Products by Development Stage
Skip to top


Ask Your Question

Fina Biotech - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: